Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Matrix
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Forge Biologics is accelerating gene therapy manufacturing: high-yield AAV manufacturing, a world-class cGMP facility, and seamless support.

Ampersand is the best way to build native product integrations with your customers' CRMs and other GTM apps. Scalable architecture…

WorldViz makes research-grade virtual reality labs for universities and professionals, including our all-in-one VR software development…

Ask your audience anything and get research-grade answers in seconds. Electric Twin builds synthetic audiences from your customer data. Up…

Learn about Grep's mission to eliminate the Expertise Tax. Built by ex-Palantir and Stanford engineers to deliver research-grade…

Discover hyperspectral imaging and Earth observation data from Wyvern. Access research-grade satellite imagery that reveals the hidden…
Overview
Trisk Bio provides scalable, preclinical AAV manufacturing for research grade and NHP studies.
News
Trisk Bio and NanoMosaic Announce Partnership for Advanced AAV Analytics
STEVENAGE, England & WALTHAM, Mass., May 11, 2026--Trisk Bio Ltd, a UK-based AAV contract development and manufacturing organisation (CDMO), and NanoMosaic, Inc., a leader in advanced analytical technologies for cell and gene therapy, today announced a pa
Read more
Report
Trisk Bio Ltd: Trisk Bio and NanoMosaic Announce Partnership for Advanced AAV Analytics
UK-based gene therapy CDMO embeds NanoMosaic's Tessie platform across its AAV development and manufacturing services. Trisk Bio Ltd, a UK-based AAV contract development and manufacturing organisation
Read more
Report
Dyno Therapeutics and Trisk Bio Announce Strategic Manufacturing Partnership Through Expanded Frontiers Program
WATERTOWN, Mass. & STEVENAGE, England, November 11, 2025--Dyno Therapeutics and Trisk Bio announce strategic manufacturing partnership through expanded Frontiers Program
Read more
Report
Report
Dyno Therapeutics, Inc.: Dyno Therapeutics and Trisk Bio Announce Strategic Manufacturing Partnership Through Expanded Frontiers Program
Expanded Dyno Frontiers Program connects therapeutic developers to a marketplace of partners ready to manufacture Dyno capsids for preclinical studies, decreasing information asymmetry, de-risking
Read more
Report

Matrix 




